ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry O35433


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name TRPV1_RAT
Primary accession number O35433
Secondary accession numbers Q920B3 Q920B4 Q9JLM0 Q9JM56 Q9JM57
Integrated into Swiss-Prot on May 10, 2005
Sequence was last modified on January 1, 1998 (Sequence version 1)
Annotations were last modified on    September 2, 2008 (Entry version 65)
Name and origin of the protein
Protein name Transient receptor potential cation channel subfamily V member 1
Synonyms TrpV1
Osm-9-like TRP channel 1
OTRPC1
Vanilloid receptor 1
Vanilloid receptor type 1-like
Capsaicin receptor
Gene name
Name: Trpv1
Synonyms: Vr1, Vr1l
From
Rattus norvegicus (Rat) [TaxID: 10116] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; Muroidea; Muridae; Murinae; Rattus.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
TISSUE=Spinal ganglion;
DOI=10.1038/39807; PubMed=9349813 [NCBI, ExPASy, EBI, Israel, Japan]
Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D.;
"The capsaicin receptor: a heat-activated ion channel in the pain pathway.";
Nature 389:816-824(1997).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND FUNCTION (ISOFORM 3).
STRAIN=Sprague-Dawley;
TISSUE=Spinal ganglion, and Trigeminal ganglion;
DOI=10.1074/jbc.275.4.2756; PubMed=10644739 [NCBI, ExPASy, EBI, Israel, Japan]
Schumacher M.A., Moff I., Sudanagunta S.P., Levine J.D.;
"Molecular cloning of an N-terminal splice variant of the capsaicin receptor. Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes.";
J. Biol. Chem. 275:2756-2762(2000).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
DOI=10.1016/S0304-3940(01)02185-1; PubMed=11578842 [NCBI, ExPASy, EBI, Israel, Japan]
Tsutsumi S., Tomioka A., Sudo M., Nakamura A., Shirakura K., Takagishi K., Kohama K.;
"Propofol activates vanilloid receptor channels expressed in human embryonic kidney 293 cells.";
Neurosci. Lett. 312:45-49(2001).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-468, AND ALTERNATIVE SPLICING.
STRAIN=Sprague-Dawley;
DOI=10.1006/geno.2001.6582; PubMed=11549313 [NCBI, ExPASy, EBI, Israel, Japan]
Xue Q., Yu Y., Trilk S.L., Jong B.E., Schumacher M.A.;
"The genomic organization of the gene encoding the vanilloid receptor: evidence for multiple splice variants.";
Genomics 76:14-20(2001).
[5]
CHARACTERIZATION OF CHANNEL PORE, AND MUTAGENESIS OF GLU-636; LYS-639; MET-644; ASP-646; GLU-648 AND GLU-651.
DOI=10.1074/jbc.M002391200; PubMed=10931826 [NCBI, ExPASy, EBI, Israel, Japan]
Garcia-Martinez C., Morenilla-Palao C., Planells-Cases R., Merino J.M., Ferrer-Montiel A.V.;
"Identification of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties.";
J. Biol. Chem. 275:32552-32558(2000).
[6]
FUNCTION.
DOI=10.1038/35050121; PubMed=11140687 [NCBI, ExPASy, EBI, Israel, Japan]
Premkumar L.S., Ahern G.P.;
"Induction of vanilloid receptor channel activity by protein kinase C.";
Nature 408:985-990(2000).
[7]
SUBCELLULAR LOCATION, AND GLYCOSYLATION AT ASN-604.
PubMed=11683872 [NCBI, ExPASy, EBI, Israel, Japan]
Jahnel R., Dreger M., Gillen C., Bender O., Kurreck J., Hucho F.;
"Biochemical characterization of the vanilloid receptor 1 expressed in a dorsal root ganglia derived cell line.";
Eur. J. Biochem. 268:5489-5496(2001).
[8]
FUNCTION, AND INTERACTION WITH PRKCG AND NTRK1.
DOI=10.1038/35082088; PubMed=11418861 [NCBI, ExPASy, EBI, Israel, Japan]
Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E., Basbaum A.I., Chao M.V., Julius D.;
"Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition.";
Nature 411:957-962(2001).
[9]
PHOSPHORYLATION AT SER-502 AND SER-800, AND MUTAGENESIS OF SER-502 AND SER-800.
DOI=10.1074/jbc.C200104200; PubMed=11884385 [NCBI, ExPASy, EBI, Israel, Japan]
Numazaki M., Tominaga T., Toyooka H., Tominaga M.;
"Direct phosphorylation of capsaicin receptor VR1 by protein kinase Cepsilon and identification of two target serine residues.";
J. Biol. Chem. 277:13375-13378(2002).
[10]
FUNCTION.
DOI=10.1074/jbc.M201551200; PubMed=12095983 [NCBI, ExPASy, EBI, Israel, Japan]
Olah Z., Karai L., Iadarola M.J.;
"Protein kinase C(alpha) is required for vanilloid receptor 1 activation. Evidence for multiple signaling pathways.";
J. Biol. Chem. 277:35752-35759(2002).
[11]
FUNCTION, AND PHOSPHORYLATION AT SER-116; THR-144; THR-370; SER-502; SER-774 AND SER-820.
DOI=10.1016/S0896-6273(02)00802-4; PubMed=12194871 [NCBI, ExPASy, EBI, Israel, Japan]
Bhave G., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. IV;
"cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation.";
Neuron 35:721-731(2002).
[12]
FUNCTION, AND INTERACTION WITH CALMODULIN.
DOI=10.1073/pnas.1337252100; PubMed=12808128 [NCBI, ExPASy, EBI, Israel, Japan]
Numazaki M., Tominaga T., Takeuchi K., Murayama N., Toyooka H., Tominaga M.;
"Structural determinant of TRPV1 desensitization interacts with calmodulin.";
Proc. Natl. Acad. Sci. U.S.A. 100:8002-8006(2003).
[13]
FUNCTION, AND MUTAGENESIS OF SER-502; THR-704 AND SER-800.
DOI=10.1073/pnas.2032100100; PubMed=14523239 [NCBI, ExPASy, EBI, Israel, Japan]
Bhave G., Hu H.J., Glauner K.S., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. IV;
"Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1).";
Proc. Natl. Acad. Sci. U.S.A. 100:12480-12485(2003).
[14]
FUNCTION, AND MUTAGENESIS OF ARG-785; LYS-788; ARG-797 AND SER-800.
DOI=10.1126/science.1083646; PubMed=12764195 [NCBI, ExPASy, EBI, Israel, Japan]
Prescott E.D., Julius D.;
"A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity.";
Science 300:1284-1288(2003).
[15]
INTERACTION WITH CSK.
DOI=10.1152/ajpcell.00113.2004; PubMed=15084474 [NCBI, ExPASy, EBI, Israel, Japan]
Jin X., Morsy N., Winston J., Pasricha P.J., Garrett K., Akbarali H.I.;
"Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase.";
Am. J. Physiol. 287:C558-C563(2004).
[16]
MUTAGENESIS OF ARG-114; ARG-115 AND GLU-761.
DOI=10.1074/jbc.M207103200; PubMed=12228246 [NCBI, ExPASy, EBI, Israel, Japan]
Jung J., Lee S.Y., Hwang S.W., Cho H., Shin J., Kang Y.S., Kim S., Oh U.;
"Agonist recognition sites in the cytosolic tails of vanilloid receptor 1.";
J. Biol. Chem. 277:44448-44454(2002).
[17]
FUNCTION, PHOSPHORYLATION AT SER-502 AND THR-704, AND MUTAGENESIS OF SER-502 AND THR-704.
DOI=10.1074/jbc.M311448200; PubMed=14630912 [NCBI, ExPASy, EBI, Israel, Japan]
Jung J., Shin J.S., Lee S.-Y., Hwang S.W., Koo J., Cho H., Oh U.;
"Phosphorylation of vanilloid receptor 1 by Ca2+/calmodulin-dependent kinase II regulates its vanilloid binding.";
J. Biol. Chem. 279:7048-7054(2004).
[18]
MUTAGENESIS OF TYR-511; MET-547 AND THR-550.
DOI=10.1074/jbc.M312577200; PubMed=14996838 [NCBI, ExPASy, EBI, Israel, Japan]
Gavva N.R., Klionsky L., Qu Y., Shi L., Tamir R., Edenson S., Zhang T.J., Viswanadhan V.N., Toth A., Pearce L.V., Vanderah T.W., Porreca F., Blumberg P.M., Lile J., Sun Y., Wild K., Louis J.C., Treanor J.J.;
"Molecular determinants of vanilloid sensitivity in TRPV1.";
J. Biol. Chem. 279:20283-20295(2004).
[19]
FUNCTION.
DOI=10.1074/jbc.M402966200; PubMed=15173182 [NCBI, ExPASy, EBI, Israel, Japan]
Hellwig N., Plant T.D., Janson W., Schafer M., Schultz G., Schaefer M.;
"TRPV1 acts as proton channel to induce acidification in nociceptive neurons.";
J. Biol. Chem. 279:34553-34561(2004).
[20]
INTERACTION WITH PRKCM, PHOSPHORYLATION AT SER-116, AND MUTAGENESIS OF SER-116.
DOI=10.1074/jbc.M410331200; PubMed=15471852 [NCBI, ExPASy, EBI, Israel, Japan]
Wang Y., Kedei N., Wang M., Wang Q.J., Huppler A.R., Toth A., Tran R., Blumberg P.M.;
"Interaction between protein kinase Cmu and the vanilloid receptor type 1.";
J. Biol. Chem. 279:53674-53682(2004).
[21]
SUBUNIT.
DOI=10.1523/JNEUROSCI.0202-04.2004; PubMed=15190102 [NCBI, ExPASy, EBI, Israel, Japan]
Garcia-Sanz N., Fernandez-Carvajal A., Morenilla-Palao C., Planells-Cases R., Fajardo-Sanchez E., Fernandez-Ballester G., Ferrer-Montiel A.;
"Identification of a tetramerization domain in the C-terminus of the vanilloid receptor.";
J. Neurosci. 24:5307-5314(2004).
[22]
X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 101-364, ATP-BINDING, AND DOMAINS ANKYRIN REPEATS.
DOI=10.1016/j.neuron.2007.05.027; PubMed=17582331 [NCBI, ExPASy, EBI, Israel, Japan]
Lishko P.V., Procko E., Jin X., Phelps C.B., Gaudet R.;
"The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity.";
Neuron 54:905-918(2007).
Comments
  • FUNCTION: Receptor-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. May be involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Activation by vanilloids, like capsaicin, and temperatures higher than 42 degrees Celsius, exhibits a time- and Ca(2+)-dependent outward rectification, followed by a long-lasting refractory state. Mild extracellular acidic pH (6.5) potentiates channel activation by noxious heat and vanilloids, whereas acidic conditions (pH <6) directly activate the channel. Can be activated by endogenous compounds, including 12-hydroperoxytetraenoic acid, and endocannabinoids, like anandamide, and bradykinin.
  • ENZYME REGULATION: Channel activity is activated via the interaction with PIRT and phosphatidylinositol-4,5-bisphosphate (PIP2). Both PIRT and PIP2 are required to activate channel activity (By similarity).
  • SUBUNIT: Intewracts with PIRT (By similarity). Self-associates. Probably homotetramer. May also form a heteromeric channel with TRPV3. Interacts with calmodulin, PRKCM and CSK. Interacts with PRKCG and NTRK1, probably by forming a trimeric complex.
  • SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
  • ALTERNATIVE PRODUCTS: 3 named isoforms [FASTA] produced by alternative splicing.
    Name1
    SynonymsVR1L1
    Isoform IDO35433-1
    This is the isoform sequence displayed in this entry.
    Name2
    SynonymsVR1L2
    Isoform IDO35433-2
    Features which should be applied to build the isoform sequence: VSP_013432.
    Name3
    SynonymsVR.5'sv
    Isoform IDO35433-3
    Note: Inactive.
    Features which should be applied to build the isoform sequence: VSP_013431, VSP_013432.
  • TISSUE SPECIFICITY: Predominantly expressed in trigeminal and dorsal root sensory ganglia. Isoform 1 and isoform 3 are also expressed in brain and peripheral blood mononuclear cells.
  • DOMAIN: The association domain (AD) is necessary for self-association.
  • PTM: Phosphorylation by PKA reverses capsaicin-induced dephosphorylation at multiple sites, probably including Ser-116 as a major phosphorylation site. Phoshphorylation by CAMKII seems to regulate binding to vanilloids. Phosphorylated and modulated by PKCM and probably PKCZ. Dephosphorylation by calcineurin seems to lead to receptor desensitization and phosphorylation by CAMKII recovers activity.
  • MISCELLANEOUS: Responses evoked by capsaicin, but not by low pH and heat, can be antagonized by capsazepine.
  • SIMILARITY: Belongs to the transient receptor family. TrpV subfamily.
  • SIMILARITY: Contains 6 ANK repeats.
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
AF029310; AAC53398.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF158248; AAF28389.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AB041029; BAA94306.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AB040873; BAA94307.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF327067; AAK83151.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF327067; AAK83152.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR T09054; T09054.
RefSeq NP_114188.1; -.
UniGene Rn.3073
3D structure databases
PDB
2NYJ; X-ray; 3.20 A; A=101-364.[ExPASy / RCSB / EBI]
2PNN; X-ray; 2.70 A; A=101-364.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 2NYJ; -.
2PNN; -.
ModBase O35433.
PTM databases
PhosphoSite O35433; -.
Organism-specific databases
RGD 628841; Trpv1.
Gene expression databases
ArrayExpress O35433; -.
GermOnline ENSRNOG00000019486; Rattus norvegicus.
Family and domain databases
InterPro IPR002110; ANK.
IPR005821; Ion_trans.
IPR004729; TRP_channel.
IPR008347; Vanilpoid_rcpt.
IPR008348; Vanilpoid_rcpt_2.
Graphical view of domain structure.
Gene3D G3DSA:1.25.40.20; ANK; 1.
Pfam PF00023; Ank; 3.
PF00520; Ion_trans; 1.
Pfam graphical view of domain structure.
PRINTS PR01415; ANKYRIN.
PR01768; TRPVRECEPTOR.
PR01769; VRL2RECEPTOR.
SMART SM00248; ANK; 4.
SMART graphical view of domain structure.
TIGRFAMs TIGR00870; trp; 1.
PROSITE PS50297; ANK_REP_REGION; 1.
PS50088; ANK_REPEAT; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS O35433.
Genome annotation databases
Ensembl ENSRNOG00000019486; Rattus norvegicus. [Contig view]
GeneID 83810; -.
KEGG rno:83810; -.
Phylogenomic databases
HOVERGEN O35433; -.
Other
ProtoNet O35433.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; ANK repeat; ATP-binding; Calcium; Calcium channel; Calcium transport; Calmodulin-binding; Cell membrane; Glycoprotein; Ion transport; Ionic channel; Membrane; Nucleotide-binding; Phosphoprotein; Repeat; Transmembrane; Transport.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
CHAIN   1   838  838     Transient receptor potential cation channel subfamily V member 1. PRO_0000215341
TOPO_DOM   1   432  432     Cytoplasmic (Potential). 
TRANSMEM   433   453  21     Potential. 
TOPO_DOM   454   476  23     Extracellular (Potential). 
TRANSMEM   477   497  21     Potential. 
TOPO_DOM   498   510  13     Cytoplasmic (Potential). 
TRANSMEM   511   531  21     Potential. 
TOPO_DOM   532   535  4     Extracellular (Potential). 
TRANSMEM   536   556  21     Potential. 
TOPO_DOM   557   579  23     Cytoplasmic (Potential). 
TRANSMEM   580   600  21     Potential. 
TOPO_DOM   601   658  58     Pore forming (Probable). 
TRANSMEM   659   679  21     Potential. 
TOPO_DOM   680   838  159     Cytoplasmic (Potential). 
REPEAT   110   152  43     ANK 1. 
REPEAT   153   199  47     ANK 2. 
REPEAT   200   246  47     ANK 3. 
REPEAT   247   282  36     ANK 4. 
REPEAT   283   331  49     ANK 5. 
REPEAT   332   358  27     ANK 6. 
REGION   684   712  29     AD. 
REGION   767   801  35     Interaction with calmodulin. 
REGION   777   792  16     Required for PIP2-mediated channel inhibition. 
MOD_RES   116   116        Phosphoserine; by PKA and PKD. 
MOD_RES   144   144        Phosphothreonine; by PKA; in vitro. 
MOD_RES   370   370        Phosphothreonine; by PKA; in vitro. 
MOD_RES   502   502        Phosphoserine. 
MOD_RES   704   704        Phosphothreonine. 
MOD_RES   774   774        Phosphoserine; by PKA; in vitro. 
MOD_RES   800   800        Phosphoserine; by PKC/PRKCZ; in vitro. 
MOD_RES   820   820        Phosphoserine; by PKA; in vitro. 
CARBOHYD   604   604        N-linked (GlcNAc...). 
VAR_SEQ   1   307        Missing (in isoform 3). VSP_013431
VAR_SEQ   348   407        Missing (in isoform 2 and isoform 3). VSP_013432
MUTAGEN   114   114        R->E: Abolishes capsaicin-evoked current and binding to resiniferatoxin. 
MUTAGEN   114   114        Missing: Abolishes sensitivity to acid. 
MUTAGEN   115   115        R->D: Abolishes capsaicin-evoked current and binding to resiniferatoxin. 
MUTAGEN   116   116        S->A: Abolishes phosphorylation by PKCM and enhances channel response to capsaicin by PKCM. 
MUTAGEN   502   502        S->A: Largely reduces PMA enhancement of capsaicin-evoked currents, but no effect on direct activation by PMA. Loss of activation by capsaicin and loss of vanilloid binding; when associated with I-704. 
MUTAGEN   511   511        Y->A: Loss of sensitivity to capsaicin. 
MUTAGEN   547   547        M->L: Reduces binding to resiniferatoxin. 
MUTAGEN   550   550        T->I: Reduces sensitivity to capsaicin 10-fold; no effect on sensitivity to resiniferatoxin. Reduces binding to resiniferatoxin. 
MUTAGEN   636   636        E->K: Abolishes channel activity. Restored channel activity; when associated with E-639. 
MUTAGEN   636   636        E->Q: Slight modification of pore attributes. 
MUTAGEN   639   639        K->E: Restored channel activity; when associated with K-636. 
MUTAGEN   644   644        M->Y: Slightly modifies channel permeability. 
MUTAGEN   646   646        D->N: Strongly reduces the affinity for pore blocker ruthenium red and lowered channel permeability for Mg(2+). 
MUTAGEN   648   648        E->Q: Minor modification of pore attributes. 
MUTAGEN   651   651        E->Q: Minor modification of pore attributes. 
MUTAGEN   704   704        T->A: No effect on PMA-induced enhancement of capsaicin-evoked currents but reduces direct activation by PMA. 
MUTAGEN   704   704        T->I: Loss of activation by capsaicin and loss of vanilloid binding; when associated with A-502. 
MUTAGEN   761   761        E->K,Q: Abolishes capsaiin-evoked current and binding to resiniferatoxin. 
MUTAGEN   761   761        Missing: Abolishes sensitivity to acid. 
MUTAGEN   785   785        R->Q: Abolishes PLC-mediated channel activity; when associated with Q-788. 
MUTAGEN   788   788        K->Q: Abolishes PLC-mediated channel activity; when associated with Q-785 or Q-797. 
MUTAGEN   797   797        R->Q: Abolishes PLC-mediated channel activity; when associated with Q-788. 
MUTAGEN   800   800        S->A: Largely reduces direct activation of by PMA and PMA-induced currents; no effect on receptor kinase-induced currents. 
CONFLICT   18    18        E -> D (in Ref. 3; BAA94307). 
CONFLICT   36    36        V -> A (in Ref. 4; AAK83151). 
CONFLICT   48    48        R -> G (in Ref. 3; BAA94306). 
CONFLICT   51    51        G -> W (in Ref. 3; BAA94306). 
CONFLICT   96    96        P -> Q (in Ref. 3; BAA94307). 
CONFLICT   179   179        V -> I (in Ref. 4; AAK83151). 
CONFLICT   735   735        K -> Q (in Ref. 3; BAA94306). 
HELIX   114   123  10      
TURN   127   131  5      
HELIX   132   139  8      
HELIX   146   148  3      
TURN   151   153  3      
HELIX   157   163  7      
HELIX   171   181  11      
TURN   182   184  3      
HELIX   187   190  4      
STRAND   196   199  4      
HELIX   204   210  7      
HELIX   214   221  8      
TURN   222   224  3      
HELIX   234   236  3      
HELIX   251   257  7      
HELIX   261   268  8      
HELIX   287   292  6      
HELIX   299   318  20